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Abstract 
Background: A breast cancer diagnosis can be a disturbing and 
stressful time for women. This study aimed to determine the 
effectiveness of mindfulness-based stress reduction treatment 
depression and optimism during chemotherapy among women with 
breast cancer. 
Methods: This study was a quasi-experimental one with a group of pre-
test, post-test, and controls. In this study, 26 women with breast cancer 
detection were identified from the referring patients to the Imam 
Hossein hospital's oncology and radiotherapy division in Tehran, 
2019-2020. Using the method of convenience sampling, the 
experimental (n=13) and control groups (n=13) were randomly 
allocated. The study group regularly engaged in mindfulness sessions 
for 8 weeks (each session lasting 90-120 minutes). In the BDI-II Beck 
Depression Inventory-II and happiness questionnaires, 
customers/clients in both the experimental and control groups 
completed. Data were analyzed by using a univariate covariance test in 
SPSS 23 software. 
Results: According to the findings, there was a significant difference in 
depression and optimism among breast cancer patients, (Pvalue<0.05). 
Also, the mean overall depression score for women with breast cancer 
in the therapy session was considerably lower than the pre-test score, 
although optimism was significantly higher than the pre-test score 
(Pvalue<0.05). 
Conclusions: The results of this study support the use of MBSR to 
minimize symptom burden in women with breast cancer. As a result, 
the effectiveness of MBSR in reducing depression symptoms and 
improving confidence has been approved. 
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Introduction 
Breast cancer is common cancer among women today and 
has a devastating impact on the lives of those who are affected 
by it including physical, economic, interpersonal, and 
psychiatric disorders.1 As seen in the literature, several 
experiences, including depression,2 anxiety,3 exhaustion, pain,4 
difficulty concentrating, social alienation, worries about 
sexuality, and self-blame.5 In women with breast cancer, 
depression is one of the most serious psychiatric illnesses.6 
According to several studies, pessimism versus optimism can 
cause a slew of negative behavioral and psychological 
consequences, as well as severe depressive symptoms in breast 
cancer patients.7 
Mohamadi rizi et al. found a significant positive 
relationship between hardness and confidence in Iran.8 These 
findings may show that people with a high level of optimism 
will feel more dedication in their lives and everyday activities 
because they look at and view events with a greater sense of 
control and a challenging attitude as an opportunity in life. In 
comparison, people with a low level of optimism are passive 
against defeats or life-threatening situations and attempt to 
avoid the situation or, in some cases, even lose their sense of 
control. Furthermore, individuals with a high degree of 
optimism see difficult situations as a struggle to overcome 
tension rather than a way to avoid or discourage it and aim to 
develop determination and emotional regulation to successfully 
overcome the challenge.7,8 Over the years, an increasing 
number of psychological treatments for cancer patients have 
been developed to improve their quality of life, overall well-
being, and optimism.1 Psychological interventions can assist 
with the emotional pain that comes with breast cancer 
diagnosis and care. Behavioral intervention efficacy testing, on 
the other hand, is characterized from a broad spectrum of 
therapies (e.g., cognitive or individual therapy) and effects 
(e.g., enhanced skills and mental health).9 
The rapidly rising incidence of psychological disorders in 
breast cancer patients has recently gained more attention. 
Patients with breast cancer can be diagnosed and treated in 
several forms, and it's well known that recovery, both before 
and after surgery, can be stressful. It's important to move 
immediately to aid breast cancer patients in coping with 
psychosocial difficulties and alleviating depression.10 
Patients with breast cancer can be given MBSR as a 
supportive or adjunctive treatment. Given the various 
challenges that breast cancer patients encounter, massive 
clinical trials are needed to assess the effectiveness of new 
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treatments that may benefit these patients. In breast cancer 
patients, MBSR (Mindfulness-based stress reduction) is an 
effective means of mitigating depression, anxiety, and stress.11 
In one meta-analysis study, MBSR has significant effects on 
physiological function, fatigue, mental health, anxiety, 
depression, frustration, pain, and mindfulness. Statistical 
significance was not reached due to a lack of data, despite the 
positive effects on pain, sleep quality, and general depressive 
symptoms.4 
The literature review revealed 14 publications that included 
ten research with a total of 1709 participants. Important post-
intervention benefits of MBSR/MBCT have been documented 
in terms of health-related quality of life, exhaustion, sleep, 
stress, anxiety, and depression as compared to standard 
treatment.12 Another study discovered that people with cancer 
who maintain a high level of sustained optimism do better than 
those who are pessimistic.13 This research aims to look at the 
effects of therapeutic therapies and how they work in the 
cancer population, to change the wellness habits of cancer 
patients, their families, and friends. 
Materials and Methods  
A quasi-experimental sample with a pre-test, post-test, and 
control group was used in this study. In this research, 26 
women with breast cancer were chosen from patients who were 
referred to Imam Hossein hospital's division of oncology and 
radiotherapy in Tehran in the years 2019-2020. The 
experimental (n=13) and control (n=13) groups were randomly 
allocated using the convenience sampling process. The patients 
were given mindfulness-based stress reduction as an 
intervention. Each of the eight sessions (90-120 minutes, once 
a week) was conducted independently and according to the 
treatment plan.14 Patients had to be between the ages of 20 and 
50, have a high school diploma, have no major physical or 
psychological problems in the past six months, non-
administration of psychiatric drugs by patients, and diagnosis 
of stage II or III breast cancer in patients who had received 
routine chemotherapy therapy. The conditions for exclusion 
were having a history of mental disorders, bipolar disorder, 
extreme personality disorders, or other cancers; engaging 
concurrently in other psychological courses; absence of 
psychoactive substance use, drug or alcohol addiction; and 
absence of more than two sessions. The convenient screening 
was used to include all participating patients in the sample. Ten 
patients out of 36 who were qualified declined to take part in 
the study. Finally, the trial was done by 26 patients (13 
participants per group; figure 1). 
According to a previous report (anxiety score: x1=47.53; 
S1=4.18, and x2=43.06; S2=4.39), the sample size for each group 
was 22 individuals.15 The measured strength is 90 percent and the 
confidence coefficient is 95 percent. Owing to the probability of 
sample depletion, only 26 people were selected for this study. Until 
attending, all participants were briefed about the study's intent and 
signed written informed consents. The hospital authorities granted 
permission, and all participants were informed of the study's intent. 
The confidentiality of the data was still preserved, and all 
questionnaires were encrypted. The collected data were analyzed 
using the SPSS-23. Descriptive statistics were used, including 
mean and standard deviation and empirical statistical measures, 
including Levene’s test homogeneity and covariance analysis 
(ANCOVA). Significant level was set at 0.05. 
The Beck depression questionnaire, the second edition (BDI-
II): This is a new version of the Beck depression inventory, which 
was created to assess the seriousness of depression.16 This tool also 
has 21 objects that are scored on a four-point Likert scale (0=not at 
all to 3=very severe), with a score range of 0 to 63. The cumulative 
number of points ranges from 0 to 63. The level of depression is 
shown by higher scores on the scale. Mild depression is scored 14-
19, moderate depression is scored 20-28, and extreme depression is 
scored 29-63 on Beck's inventory. The score of this tool is obtained 
by summing the score of the items and a higher score means more 
depression. Beck and Clark reported its reliability by Cronbach's 
alpha method of 0.89.17 The internal consistency of this 
questionnaire was also reported to be 0.91.16 Also, its internal 
consistency in Iran by Cronbach's alpha method is 0.94.18 In the 
present study, Cronbach's alpha reliability coefficients for this 
questionnaire were calculated to be 0.89. 
Life orientation test-revised: Habitual optimism was tested 
with the LOT-R19 with three items each, along with four filler 
items, it consists of two subscales, optimism, and pessimism. The 
test was initially supposed to be a one-dimensional instrument. 
Each item needs a five-point Likert scale response, ranging from 0 
(strongly disagree) to 4 (strongly agree) (strongly agree). For 
subscales, the scale ranges from 0 to 12.13 The life orientation test 
(LOT) questionnaire to measure optimism which consists of 10 
items and has a five-point Likert scale ranging from 0 to 4. The 
scoring range is from 0 to 24. Higher scores indicate higher 
optimism. It is worth noting that scores higher and lower than 
average are considered as high and low optimism, respectively.20,21 
Cronbach's alpha reliability coefficients for this questionnaire were 
determined to be 0.78 in the present analysis. 
The study was performed at Imam Hossein hospital's division 
of oncology in Tehran by two master clinical psychologists who 
were familiar enough with the intervention (they have 
qualifications for administering this treatment) and met ethical 
research requirements such as informed consent and keeping 
participants' secrets. Participants were tested twice: once at 
baseline before intervention in experimental groups and again after 
intervention in control groups. During 8 weekly group sessions 
lasting 90-120 minutes, the first study client obtained therapy 
based on a mindfulness-based stress management protocol.14 The 
following is a list of guidelines for how to deliver mindfulness-
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Figure 1. The flow diagram of the study 
Table 1. Content and treatment sessions 
Session I: The implementation of the automated guidance system/ learning how to use present moment perception of body feelings, perceptions, and emotions in 
reducing stress/ eating raisins (Object attention training), providing feedback and dialog on the practice/three-minute breathing/assigning homework for the next week 
and handing out first-session leaflets and meditation CDs. 
Session 2: Re-examination of the body/feedback and discussion of the body examination practice/breathing mindfulness meditation/yoga stretching 
exercise/distribution of second session leaflets and meditation CDs. 
Session 3: Conscious sitting with knowledge of breathing (sitting meditation)/practicing yoga exercises (in the hospital chapel)/practicing three-minute 
breathing/distribution of third session leaflets and videotapes of yoga practices. 
Session 4: Re-enacting the body examination/doing exercises related to conscious yoga (in the hospital chapel)/5-minute “seeing or hearing” practice/re-enacting 
conscious sitting with knowledge of breathing and body/distribution of fourth session leaflets and meditation CDs 
Session 5: Practicing breathing/re-practicing conscious sitting (awareness of breathing, body, sounds, and emotions)/explaining tension and understanding the 
responses of participants/examining awareness of good and negative occurrences on feelings, thoughts, and feelings in the body/conscious yoga exercises/three-minute 
breathing/distribution of leaflets 
Session 6: Practicing conscious yoga/doing sitting meditation (sound and thinking mindfulness)/distribution of sixth session leaflets and videotape number 4 to 
participants. 
Session 7: Mountain meditation/sleep hygiene/repetition of previous session exercises/making a list of fun activities/distribution of seventh session leaflets 
Session 8: Practice body inspections/overview of the entire program/examination and discussion of programs/meditation with mortar, beads, and marbles 
 
Excluded (n=50) 
Not meeting inclusion criteria (n=45) 
Declined to participate (n=5) 
Evaluated for eligibility (n=86) 
Randomized (n=36) 
Intervention (n=18) Control (n=18) 
Absence of intervention (n=5) 
Final (n=13) 
Declined to answer questionnaire (n=5) 
 
Final (n=13) 
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Results 
The distribution of age, education, and employment status of 
women with breast cancer in table 2 is presented. (42%) of the 
patients belonged to the age group of 30-40 years, 49% of the 
patients had a bachelor's degree and 69% were housewives. 
From Table 4, it is obvious that there is a substantial gap 
between the two classes. In the post-test depression variable, 
there is a substantial difference between the experimental and 
control groups (Pvalue>0.001; F=272.926). As a result, it can be 
said with 95% certainty that mindfulness reduces depression in 
breast cancer patients. Table 4 shows a significant disparity 
between the two classes. The testing and control groups have a 
significant confidence gap in the post-test (Pvalue>0.001; 
F=42.015). As a result, it can be said with 95 percent accuracy 
that mindfulness has an effect on women with breast cancer's 
optimism. 
 
Table 2. Comparison of sociodemographic characteristics of the patients 









Under- diploma 9 
Diploma 21 
Bachelor 49 









Table 4. Results of ANCOVA test in experimental and control groups with control of pre-test effect 
Pvalue F Mean square Degree of freedom Sum of square Source of change Variables 
0.067 321.344 866.100 1 866.100 Pre-test 
Depression 0.00 272.926 376.196 1 376.196 Group 
 51.00 37 1.378 Error 
0.087 213.152 461.491 1 461.491 Pre-test 
Optimism 0.00 42.015 61.330 1 61.330 Group 
 1.460 37 54.009 Error 
 
Discussion 
The present study is one of the few studies which examines 
the status of depression and optimism in Iranian women with 
breast cancer and investigates the mindfulness approach with 
those variables. The effects of mindfulness on depression and 
optimism in breast cancer patients were investigated in this 
research. According to the findings, mindfulness practice helps 
these people feel less depressed and more optimistic. Few 
studies have looked at the efficacy of mindfulness methods in 
cancer patients.11,21-26 Just a few studies were identified after a 
thorough literature review that specifically investigated the 
efficacy of mindfulness interventions in the cancer 
environment, particularly on these variables, but this still 
provides valuable pilot evidence.  
Only a few research has looked at how effective 
mindfulness approaches are for cancer patients.11,21-26 Just a few 
experiments focused on the effects of mindfulness 
interventions in the cancer environment, specifically on these 
factors, were identified after a thorough literature review, but 
this still provides valuable pilot evidence. Cancer diagnosis and 
recovery, on the other hand, are often related to physical and 
mental health problems. Patients with cancer often complain of 
pain, exhaustion, depression, and anxiety. Approximately half 
of all cancer patients feel exhaustion, and more than a third 
experienced severe psychological distress.4,12 
As a result, mindfulness-based stress relief is beneficial not 
only to patients receiving successful therapies but also to 
survivors once they have completed therapy. A randomized 
study of breast cancer survivors found that mindfulness-based 
stress control therapy reduced anxiety, fear of recurrence, as 
well as physical signs of exhaustion severity and fatigue 
interference.10 Long-term benefits from mindfulness-based 
stress reduction were seen in those suffering from cancer-
related cognitive impairment, a fatigue-related symptom that 
hurts quality of life.11,22  
Table 3. Frequency, mean, standard deviation, minimum, and maximum scores obtained in pre-test and post-test 
Max Min Mean±SD Groups Sub-groups Variables 
34 17 24±5.8 Pre-test 
Experimental 
Depression 
32 16 17.6±5.45 Post-test 
29 11 22.7±4.520 Pre-test 
Control 
31 17 22.65±4.30 Post-test 
23 9 15.6±3.89 Pre-test 
Experimental 
Optimism 
21 10 18.25±3.99 Post-test 
26 12 16.1±3.29 Pre-test 
Control 
21 10 16.2±3.33 Post-test 
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A systematic review analysis found a strong connection 
between participants' well-being immediately after diagnosis or 
treatment and their long-term follow-up. When it came to 
hoping and optimism, the findings showed that a higher level 
of initial optimism indicated more positive optimism and long-
term follow-up well-being, which in all of the follow-up trials 
was one year after diagnosis or treatment.1 Although the 
processes behind meditation's health effects are still 
unidentified, recent research indicates that it may affect 
structural and functional changes in the brain that regulate 
consciousness, mood, and self-awareness.23 
An experimental research found that mindful breathing 
practice resulted in greater “decentering” from internal 
interactions and a reduction in reactivity to repetitive thinking 
as compared to incremental muscle relaxing or loving-kindness 
meditation.24 Furthermore, mindfulness-based stress mitigation 
may modulate the immune system and enhance cellular 
resilience by improving telomerase activity, a known marker of 
cellular aging and psychological danger, as evidenced by a 
decrease in the ratio of T1 proinflammatory to T2 anti-
inflammatory lymphocytes.25  
According to the findings of this report, the healthcare team 
should have a detailed understanding of the personality 
characteristics of cancer patients, as measures such as 
dedication, power, and difficulty, as well as optimism, can 
influence a patient's response to a treatment plan or nursing 
care. As a result, interventional procedures such as consultation will 
help to alleviate cancer patients' stress and encourage their resiliency. 
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